Skip to main content
Isofol Medical logo

Isofol Medical — Investor Relations & Filings

Ticker · ISOFOL ISIN · SE0009581051 LEI · 549300MCXYAHG7VBHX75 ST Professional, scientific and technical activities
Open in API
Filings indexed 208 across all filing types
Latest filing 2023-11-09 AGM Information
Country SE Sweden
Listing ST ISOFOL

About Isofol Medical

https://isofolmedical.com/

Isofol Medical is a clinical-stage biotechnology company dedicated to improving treatments for severe forms of cancer. The company's primary focus is the development of its lead drug candidate, arfolitixorin. This next-generation, folate-based therapy is designed to enhance the efficacy of standard cancer treatments, such as chemotherapy. Arfolitixorin is the active metabolite of commonly used folate-based drugs, potentially offering a therapeutic benefit to a broader patient population by bypassing complex metabolic activation steps. The company's goal is to help more patients respond better to their treatment, thereby improving their prognosis.

Recent filings

Filing Released Lang Actions
Isofol har erhållit begäran om att kalla till extra bolagsstämma
AGM Information Classification · 95% confidence The document is a press release from Isofol Medical AB announcing that they have received a request from shareholders (representing at least 10% of shares) to convene an Extraordinary General Meeting (EGM) for the election of additional board members. The key phrases are 'begäran om att kalla till extra bolagsstämma' (request to call an extraordinary general meeting) and the announcement that the official notice ('Kallelse') will be published soon. This relates directly to shareholder meetings and voting procedures. While it is an announcement about a meeting, the core subject matter is the process leading up to a shareholder vote, which aligns best with the scope of AGM-R (AGM Information) or potentially DVA (Declaration of Voting Results & Voting Rights Announcements), although DVA is usually for the *results*. Since this is about calling a meeting for voting purposes, AGM-R is the most appropriate fit among the provided options, as EGMs are functionally similar to AGMs in terms of governance structure, or it could be considered a general governance/shareholder communication. Given the options, AGM-R covers general meeting announcements, even if it's an EGM. It is not a DEF 14A (Remuneration) or a DVA (Results). It is a specific announcement about a meeting, not a general regulatory filing (RNS) or a report (AR/IR).
2023-11-09 Swedish
Isofol has obtained a request to call an extraordinary general meeting
AGM Information Classification · 99% confidence The document explicitly states that Isofol Medical AB has 'obtained a request to call an extraordinary general meeting for the election of additional board members.' This announcement concerns the process and intent to hold a shareholder meeting (EGM), which is related to corporate governance and shareholder actions. While it is not the final voting result (DVA) or the proxy materials (PSI), it is a direct announcement regarding the calling of a general meeting. Given the options, this type of corporate action announcement, especially concerning board elections, fits best under general corporate governance or regulatory announcements. Since there is no specific code for 'Notice to Call Meeting,' and it is a formal announcement about a shareholder meeting process, it is closely related to AGM/EGM activities. However, the closest fit among the provided codes that deals with shareholder meetings and governance structure changes is often captured by governance-related filings or, if it were a final result, DVA. Since it is an announcement *about* calling a meeting, and not the meeting materials themselves, it is a general corporate announcement. Given the context of board elections, it touches upon governance (CGR) or a general regulatory filing (RNS). Since it is a specific announcement about convening a meeting, and not a standard report, RNS is a possibility, but let's re-evaluate the definitions. It is not a DEF 14A (Remuneration), not a DVA (Voting Results), and not an AGM-R (Presentation materials). It is an announcement of a corporate event. In many databases, announcements regarding the calling of EGMs fall under general regulatory news. Given the options, and the focus on the *process* of calling a meeting, RNS (Regulatory Filings - fallback) is appropriate, but let's check if it fits better elsewhere. It is an announcement about a corporate governance event (board election at an EGM). If we consider the closest related event, it is related to the AGM process. Since it is an announcement about calling a meeting, and not the final materials, RNS is the safest fallback for a specific, non-standard announcement. However, if we interpret 'AGM-R' broadly as any material related to the AGM process, it might fit, but AGM-R is defined as 'Presentations and materials shared during the Annual General Meeting'. This is a pre-meeting announcement. Therefore, RNS is the most appropriate fallback for this specific type of corporate action announcement.
2023-11-09 English
Isofol har utsett valberedningen inför årsstämman 2024
Board/Management Information Classification · 99% confidence The document is a press release announcing the appointment of the members of the Nomination Committee (Valberedningen) for the upcoming Annual General Meeting (Årsstämman) in 2024. This announcement concerns the composition of the body responsible for nominating directors and setting remuneration, which falls under corporate governance and shareholder meeting preparation. The specific content relates directly to the structure and process leading up to the AGM, specifically concerning director nominations. This aligns best with 'Board/Management Information' (MANG) as it deals with the composition of a key governance body (the Nomination Committee, which proposes board members), or potentially 'Governance Information' (CGR). However, since the focus is explicitly on the *appointment* of the committee members for the AGM, and not a general governance report, MANG is a strong fit, as it covers changes in board-related structures. Given the options, MANG (Board/Management Information) is the most precise fit for an announcement detailing the composition of the body that nominates directors for the AGM.
2023-11-08 Swedish
Isofol appoints nomination committee ahead of the Annual General Meeting 2024
Board/Management Information Classification · 99% confidence The document explicitly discusses the appointment of members for the 'nomination committee for the Annual General Meeting 2024'. While it relates to the AGM, the core content is the announcement of the committee members and the process for submitting proposals to this committee, which is a preparatory step for the AGM. This type of announcement, focusing on governance structure related to shareholder meetings (specifically the nomination committee), aligns best with 'AGM Information' (AGM-R) as it is directly tied to the upcoming AGM proceedings and composition, rather than being the meeting presentation itself or a general governance report (CGR). It is not a proxy statement (PSI) or a declaration of voting results (DVA). Given the direct reference to the AGM and the nomination committee formation, AGM-R is the most precise fit.
2023-11-08 English
Report Publication Announcement 2023
Report Publication Announcement Classification · 95% confidence The document is a press release announcing the availability of the company's half-year report (halvårsrapport). It provides a brief summary of key financial highlights (net sales, profit, earnings per share) and significant events, but explicitly states that the full report is available on the company's website. Following the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) rather than the full interim report itself. H2 2023
2023-08-22 Swedish
Report Publication Announcement 2023
Report Publication Announcement Classification · 95% confidence The document is a press release announcing the publication of an interim report. It contains key financial highlights (revenue, result for the period, EPS) for the second quarter and first half of 2023, but explicitly states that the full interim report is available on the company's website. Per the 'Menu vs Meal' rule, since this is a short announcement (under 5,000 characters) directing readers to the full report, it is classified as a Report Publication Announcement (RPA). H1 2023
2023-08-22 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.